Hyatt Hotels Corporation vs Hinge Health Inc. Class A Common Stock — how do they compare? Hyatt Hotels Corporation trades at $160.32 (market cap $15.11B), while Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B). The key difference: Hyatt Hotels Corporation is the larger of the two by market cap, and Hyatt Hotels Corporation pays a 0.37% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hyatt Hotels Corporation for 149 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| H | HNGE | |
|---|---|---|
Market Cap | $15.11B | $8.47B |
Volume | 769,803 | 1,624,526 |
Sector | Consumer Cyclical | Health |
52-Week High | $202.09 | $105.14 |
52-Week Low | $135.42 | $31.17 |
Typical Hold Time | 149 Days | 0 Days |
Enterprise Value | $19.01B | $8.09B |
Dividend Yield | 0.37% | — |
Signals from Pluang's Aura AI — not financial advice
Hyatt Hotels (H) trades at $162.92, up 1.08% on the day, with a bullish technical signal and recent earnings beats in Q4 2025, Q1 2026, and Q2 2026. The stock is supported by a consensus price target of $197.92, representing a 21% upside, and positive news including a strategic loyalty collaboration with Delta Air Lines and portfolio expansion. However, valuation metrics like a P/E of 197.93 and a net income margin of 1.1% indicate premium pricing relative to modest profitability.
The outlook for H is cautiously optimistic, driven by earnings momentum and strategic initiatives, but high valuation and fluctuating cash flows pose risks. Investors should weigh the potential for continued operational growth against the stock's rich multiples and macroeconomic sensitivity in the hospitality sector.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Hyatt is an operator of 1,162 owned (5% of total rooms) and managed and franchise (95%) properties across roughly 20 upscale luxury brands, which includes vacation brands (Apple Leisure Group, Hyatt Ziva and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, and the wellness brand Miraval. Hyatt acquired Two Roads in November 2018 and Apple Leisure Group in 2021. The regional exposure as a percentage of total rooms is 66% Americas, 18% Asia-Pacific, and 16% rest of world.
Read more on H →Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →